XML 47 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2022
Summary of Stock option and restricted stock activity

A summary of stock option and restricted stock activity under the 2022 Plan and Inducement Grants during the nine months ended September 30, 2022 and 2021 is presented below:

(in thousands)

Options

Inducement Grants

RSAs

Outstanding at December 31, 2020

 

756

180

352

Granted

 

97

61

463

Options Exercised/RSAs Vested

 

(5)

(126)

 (1)

Forfeited

 

(74)

(61)

Expired

 

Outstanding at September 30, 2021

 

774

241

628

Outstanding at December 31, 2021

 

747

241

707

Granted

 

36

723

Options Exercised/RSAs Vested

 

(16)

(234)

 (2)

Forfeited

 

(58)

(46)

Expired

 

Outstanding at September 30, 2022

 

709

241

1,150

(1)Includes 28 thousand shares purchased from employees to cover employee income taxes related to income earned upon vesting of restricted stock. The shares purchased are held in treasury and the $0.9 million total purchase price for the shares is included in Treasury stock in our accompanying unaudited interim condensed consolidated balance sheets.
(2)Includes 63 thousand shares purchased from employees to cover employee income taxes related to income earned upon vesting of restricted stock. The shares purchased are held in treasury and the $1.9 million total purchase price for the shares is included in Treasury stock in our accompanying unaudited interim condensed consolidated balance sheets.
2016 Employee Stock Purchase Plan  
Summary of allocated expense

(in thousands)

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2022

    

2021

    

2022

    

2021

    

Cost of sales

$

11

$

3

$

40

$

11

Research and development

 

10

 

5

 

31

 

16

Selling, general, and administrative

 

82

 

20

 

142

 

66

$

103

$

28

$

213

$

93

2022 Plan  
Summary of allocated expense

(in thousands)

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2022

    

2021

    

2022

    

2021

    

Cost of sales

$

134

$

2

$

393

$

4

Research and development

 

186

 

144

 

531

 

407

Selling, general, and administrative

 

3,447

 

2,634

 

9,725

 

7,017

$

3,767

$

2,780

$

10,649

$

7,428